[4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate

C46H56N14O20P2 — CID 137208800

IUPAC[4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate
SMILESCC(C)C(NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)N[C@H](C)C(=O)Nc1ccc(COC(=O)Nc2ncnc3c2ncn3[C@@H]2O[C@@H]3COP(=O)(O)O[C@@H]4[C@H](O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)(O)OC3C2O)cc1
InChIInChI=1S/C46H56N14O20P2/c1-21(2)30(54-27(61)7-5-4-6-14-58-28(62)12-13-29(58)63)41(67)52-22(3)40(66)53-24-10-8-23(9-11-24)15-74-46(69)55-37-31-38(49-18-48-37)59(19-50-31)43-33(64)35-25(77-43)16-75-82(72,73)80-36-26(17-76-81(70,71)79-35)78-44(34(36)65)60-20-51-32-39(60)56-45(47)57-42(32)68/h8-13,18-22,25-26,30,33-36,43-44,64-65H,4-7,14-17H2,1-3H3,(H,52,67)(H,53,66)(H,54,61)(H,70,71)(H,72,73)(H3,47,56,57,68)(H,48,49,55,69)/t22-,25-,26-,30?,33?,34+,35?,36+,43-,44-/m1/s1
InChIKeyLYBBNXLPTBIBMH-JWUNOXTISA-N
MW1186.98 g/mol
LogP-0.11
Rot. Bonds17

About [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate

[4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate (PubChem CID 137208800) has the molecular formula C46H56N14O20P2 and a molecular weight of 1186.98 g/mol. Its IUPAC name is [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate.

Molecular Properties

Compound Name[4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate
PubChem CID137208800
Molecular FormulaC46H56N14O20P2
Molecular Weight1186.98 g/mol
Exact Mass1186.33
IUPAC Name[4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate
SMILESCC(C)C(NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)N[C@H](C)C(=O)Nc1ccc(COC(=O)Nc2ncnc3c2ncn3[C@@H]2O[C@@H]3COP(=O)(O)O[C@@H]4[C@H](O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)(O)OC3C2O)cc1
InChIInChI=1S/C46H56N14O20P2/c1-21(2)30(54-27(61)7-5-4-6-14-58-28(62)12-13-29(58)63)41(67)52-22(3)40(66)53-24-10-8-23(9-11-24)15-74-46(69)55-37-31-38(49-18-48-37)59(19-50-31)43-33(64)35-25(77-43)16-75-82(72,73)80-36-26(17-76-81(70,71)79-35)78-44(34(36)65)60-20-51-32-39(60)56-45(47)57-42(32)68/h8-13,18-22,25-26,30,33-36,43-44,64-65H,4-7,14-17H2,1-3H3,(H,52,67)(H,53,66)(H,54,61)(H,70,71)(H,72,73)(H3,47,56,57,68)(H,48,49,55,69)/t22-,25-,26-,30?,33?,34+,35?,36+,43-,44-/m1/s1
InChIKeyLYBBNXLPTBIBMH-JWUNOXTISA-N
XLogP-0.11
TPSA466.64 Ų
H-Bond Donors10
H-Bond Acceptors26
Rotatable Bonds17
Heavy Atoms82
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001186.98
LogP ≤ 5-0.11
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate?
The IUPAC name of [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate (CID 137208800) is [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate.
What is the SMILES notation for [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate?
The canonical SMILES for [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate is CC(C)C(NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)N[C@H](C)C(=O)Nc1ccc(COC(=O)Nc2ncnc3c2ncn3[C@@H]2O[C@@H]3COP(=O)(O)O[C@@H]4[C@H](O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)(O)OC3C2O)cc1.
What is the InChIKey of [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate?
The InChIKey is LYBBNXLPTBIBMH-JWUNOXTISA-N. The full InChI is InChI=1S/C46H56N14O20P2/c1-21(2)30(54-27(61)7-5-4-6-14-58-28(62)12-13-29(58)63)41(67)52-22(3)40(66)53-24-10-8-23(9-11-24)15-74-46(69)55-37-31-38(49-18-48-37)59(19-50-31)43-33(64)35-25(77-43)16-75-82(72,73)80-36-26(17-76-81(70,71)79-35)78-44(34(36)65)60-20-51-32-39(60)56-45(47)57-42(32)68/h8-13,18-22,25-26,30,33-36,43-44,64-65H,4-7,14-17H2,1-3H3,(H,52,67)(H,53,66)(H,54,61)(H,70,71)(H,72,73)(H3,47,56,57,68)(H,48,49,55,69)/t22-,25-,26-,30?,33?,34+,35?,36+,43-,44-/m1/s1.
What are the key properties of [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate?
[4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate has a molecular weight of 1186.98 g/mol, XLogP of -0.11, 17 rotatable bonds, 10 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[(2R)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl N-[9-[(1R,6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]purin-6-yl]carbamate is sourced from PubChem (CID 137208800), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).